Sina Rashedi
@SinaRsh
Followers
715
Following
2K
Media
5
Statuses
332
MD-MPH; Postdoctoral Research Fellow @BrighamWomens @harvardmed; @bwh_postdocs; Editorial Board @PLOSONE; #cardiology #thrombosis
Boston, MA, USA
Joined March 2014
Honored to be a part of the HI-PRO trial, presented today by my mentor @GregoryPiazza4 at #ESCCongress2025 Published @NEJM
https://t.co/DSAM4mstXB In provoked VTE & enduring risk, Extended low-dose apixaban vs placebo: ⬇️Risk of recurrent VTE with low risk of major🩸
nejm.org
The appropriate duration of anticoagulation for venous thromboembolism (VTE) in patients who have a transient provoking factor (e.g., surgery, trauma, or immobility) and concomitant enduring risk f...
Presented at #ESCCongress: In patients with provoked venous thromboembolism and ongoing risk factors, extended treatment with low-dose apixaban for 12 months resulted in a lower risk of recurrent VTE than placebo, with a low risk of major bleeding. Full HI-PRO trial results:
13
13
50
Thrilled and humbled to receive a New Investigator Award 🏆 for our RIME paper on sense of #belonging in medicine! This recognition means so much. Belonging is foundational to well-being in our profession. Grateful to #AAMC25 for this opportunity to share our work. #MedEd
16
6
79
Our new publication in JASE @ASE360 explores real-world adherence to guideline-recommended surveillance echocardiography in patients with asymptomatic severe AS. Read more 🔗 https://t.co/CXNGeHEc1q
@PennCardiology @mariellesc1
@JBourqueMD @sri_adu @EmekaAnyanwu @Ellen_A_Boakye
onlinejase.com
7
7
34
✨Yesterday, I had the opportunity to present at ACC midwest chapter, where our collaboration on Pericardial adipose tissue quantification received a best abstract awards. 🎉Congrats to @zahra_es97, @DrLopezJimenez, @Doctora_BetsyMI, @MedinaInojosaMD and the team.
6
4
94
Excited to present our @AcadMedJournal RIME paper on measuring sense of #belonging in medicine at #AAMC2025! 🎉 📍Tues 11/4, 10:15 AM CT, Room 214 📄 Session: Psychological & Emotional Influences on Current & Future Physicians Hope to see you there! 🌟
5
5
41
📢 Check out our new paper in @GreenJournal! Among ~86K patients with #Stroke, 10% had active #Cancer. Only ~15% received anticoagulation. Over 6 mo: 🧠🫀Thromboembolism IR=38.4 (AC vs no AC: HR 1.21, 95% CI 0.91–1.61) 🩸 Bleeding IR=20.9 @PennNeurology 🔗 https://t.co/mw174rqKqY
2
5
23
STRIVE trial: Adjunctive intracoronary low-dose t-PA during primary PCI did not improve microvascular obstruction or 30-day MACE vs. placebo in STEMI patients with large thrombus burden. #TCT2025 View it here: https://t.co/AmOL8e8qT7
1
5
20
First timer #ACG2025 🤩 - reconnecting with old friends, making new ones, and learning from incredible talks. Oh, and winning Outstanding Presenter Award was the cherry on top! 🎉 Thank you to everyone who made it so memorable.
18
5
97
Grateful and humbled! Our poster received both the Presidential Award and Outstanding Presentation Award at #ACG2025! Many thanks to my mentor @vivicality and our fantastic team at @UCSF_BCHSI ! https://t.co/4KuF5Xbjhm
5
4
48
Does treating gut inflammation resolve joint pain in #IBD? Our study suggests it's not that simple. Come see the data! 🎯 ⏰Presenting Mon 10/27 - P3342 Grateful for my amazing mentors @JillGaidosMD and @GIDocAnnie and our entire research team! 🙏 #ACG2025 #GastroTwitter
9
5
60
Check out our new paper on global cardiovascular deaths linked to high BMI!
🌍 A global look-back (1990–2021) + projections forward: rising cardiovascular mortality linked to high BMI. Obesity = major threat to heart health worldwide. 🔗 https://t.co/Pijr22qIc0
@khurramn1
#Obesity #HeartHealth #CVDTrends #Prevention
2
1
6
Incredible experience presenting my projects at @DOM_UCLA Research Day alongside my co-residents and chiefs. Grateful to be part of a program that fosters curiosity, mentorship, and collaboration.🫀 @uclaimchiefs @uclaCVfellows @VirginiaSHahnMD @UCLA @hopkinsheart
5
8
81
🚨 Hot off the press! Our new publication is out, check it out🔥 Supraventricular Tachycardia Burden on Ambulatory ECG Monitoring Predicts Recurrent Atrial Fibrillation Following Catheter Ablation for Atrial Fibrillation - American Journal of Cardiology https://t.co/xlS8OGK5Ef
3
6
22
In addition to benefitting from the wisdom of a stellar multidisciplinary team and wonderful Editor guidance from @JACCJournals editors, much credit goes to our 💫 fellow @SinaRsh who did amazing work! And this is his #2 first-authored paper in JACC this year!!
Fibrinolytic therapy remains a major mgmt option for thromboembolic diseases. Advances in catheter-directed techniques, dosing strategies, & novel agents may expand therapeutic options & improve the safety of fibrinolytic therapy. https://t.co/pTAdP6G1oc
#JACC @bbikdeli @hmkyale
1
6
24
Fibrinolytic therapy remains a major mgmt option for thromboembolic diseases. Advances in catheter-directed techniques, dosing strategies, & novel agents may expand therapeutic options & improve the safety of fibrinolytic therapy. https://t.co/pTAdP6G1oc
#JACC @bbikdeli @hmkyale
2
115
332
#COATEDAIR closer & closer to 🏁. 2x2 factorial RCT in ASCVD: 🔎1 Coated vs plain ASA 🔎2 Hybrid vs routine strategy ⬇ CVD of 😷💨 🙏🏻to pts trust & devotion of all investigators https://t.co/gOSeKYn56K
@bbikdeli @AzitaTalasaz
0
11
21
Thrilled to share our recent @JACCJournals State-of-the-Art Review on #fibrinolytic Tx for different #thromboembolic diseases https://t.co/NOeZl8hCCA Grateful to the outstanding experts I had the privilege to learn from and collaborate with on this paper! #MedTwitter
jacc.org
🚨🚨 #Fibrinolytic tx for #cardiovascular conditions : In @JACCJournals we show current use, #RCT data on #MI 🫀#PE 🫁 #DVT 🦵, #stroke 🧠, & future directions! @MGBResearchNews @harvardmed @YaleCardiology @Vasculearn #Cardiology @SinaRsh #Thrombosis 👇 https://t.co/IH5sh6S50V
13
10
64
🚨🚨 #Fibrinolytic tx for #cardiovascular conditions : In @JACCJournals we show current use, #RCT data on #MI 🫀#PE 🫁 #DVT 🦵, #stroke 🧠, & future directions! @MGBResearchNews @harvardmed @YaleCardiology @Vasculearn #Cardiology @SinaRsh #Thrombosis 👇 https://t.co/IH5sh6S50V
1
24
48
What a phenomenal start to #UCLAHF with the one & only @gcfmd HFpEF/HFmrEF: 3 pillars of proven therapy ➡️ SGLT2i ➡️ nsMRA ➡️ GLP1/GLP1-GIP RA Start all 3 definitively proven disease-modifying drugs without delay, or in rapid sequence. @DOM_UCLA @uclaCVfellows @uclaimchiefs
2
6
31
Honored to present results of @vestibularveda registry at #Neurovestibular session, #ANA2025 @TheNewANA1. Deep gratitude to session chairs @NCherayil & @lindseydelott, my mentor @akherad19, NVV division & Dept of Neurology @HopkinsMedicine for the incredible support.
2
2
10
In the STRIKE‐PE study, computer assisted vacuum thrombectomy for pulmonary embolism rapidly improved right heart function and symptoms, with a low rate of major adverse events. #AHAJournals @drandrewsharp
https://t.co/OcIXwH1tDt
0
4
10